Clinical signs associated with COMPOUND_XXX administration were limited to an increased incidence of skin discoloration at injection sites at doses ≥ 1.0 mg / kg .
Clinical signs associated with COMPOUND_XXX administration were limited to an increased incidence of skin discoloration at injection sites at doses ≥ 1.0 mg / kg .
O O O O O O O O O O B-MANIFESTATION_FINDING O O B-FINDING I-FINDING O B-SPECIMEN I-SPECIMEN O O O B-DOSE I-DOSE I-DOSE I-DOSE O